BETA

2 Amendments of Seán KELLY related to 2020/2071(INI)

Amendment 5 #
Draft opinion
Paragraph 1
1. Notes that the COVID-19 pandemic has revealed in the starkest possible terms the vital role played by functioning global supply chains for medical products, and in particular for medicines; emphasises that an open, enforceable rules-based trading system is fundamental to ensuring the global availability of medicines;
2020/05/18
Committee: INTA
Amendment 15 #
Draft opinion
Paragraph 2
2. Recognises that the EU depends on a narrow set of countries for a large proportion of its imports of active pharmaceutical ingredients and chemical raw materials; stresses that this over- reliance can pose a risk when limitations in production capacity, excess demand or protectionist measures threaten the proper functioning of global supply chains and potentially undermine the availability of medicines in the EU; calls on the Commission to present a long-term strategy focused on ensuring the EU’s open strategic autonomy in health, incorporating exploration into new trading partners for diversification of supply chains;
2020/05/18
Committee: INTA